ALX Oncology Holdings Inc. (ALXO) vs Immuneering Corporation (IMRX)
A side-by-side comparison of ALX Oncology Holdings Inc. and Immuneering Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALXO
ALX Oncology Holdings Inc.
$1.19HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
IMRX
Immuneering Corporation
$4.04HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ALXO vs IMRX
growth of $100 · dividends reinvested · last 5yALXO -98.0% (-54.1%/yr)IMRX -77.0% (-25.5%/yr)IMRX compounded faster over this window
Log scale — wide-divergence pair
ALXO IMRX
ALXO vs IMRX: by the numbers
- •ALXO is the larger company ($160M vs $147M market cap).
Metrics side by side
Valuation
| Metric | ALXO | IMRX |
|---|---|---|
| P/B ratio | 1.18 | 0.77 |
Profitability
| Metric | ALXO | IMRX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -59.40% | -30.03% |
| ROIC | -56.53% | -32.73% |
Growth (annualized)
| Metric | ALXO | IMRX |
|---|---|---|
| Total return CAGR (5Y) | -56.07% | -32.77% |
Frequently asked
- How have ALXO and IMRX total returns compared?
- Over the past 5 years, ALXO delivered -56.07% and IMRX delivered -32.77% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.